Search results
Showing 31 to 45 of 145 results for allergy
Question Communicating information about drug allergy:- In people with suspected or confirmed drug allergies, are...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired pneumonia, including bacterial pneumonia secondary to COVID-19, in babies over 1 month (corrected gestational age), children, young people and adults. It aims to optimise antibiotic use and reduce antibiotic resistance.
antibiotic challenge for diagnosing antibiotic allergy in children:- In children who have a suspected allergy to an...
In development Reference number: GID-TA11566 Expected publication date: TBC
Prevalence and natural history of non-IgE-mediated food allergy:- How common are non-IgE-mediated food allergies in...
CG183/1 Question Designing systems for documenting drug allergy:- Which documentation strategies would be most clinically and cost...
non-IgE-mediated food allergy:- Which features in the clinical history best predict the presence of non-IgEmediated food...
their care pathway to diagnosis of food allergy:- What do children and young people with IgE-mediated food allergy and...
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)
Summary of the evidence on delafloxacin for community-acquired pneumonia in adults
This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.
WP1048 for treating grass pollen allergy in people aged 18 to 60 [TSID10467]
Awaiting development Reference number: GID-TA11305 Expected publication date: TBC
Omalizumab for previously treated chronic spontaneous urticaria (TA339)
Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.
Sebetralstat for treating acute attacks of hereditary angioedema in people aged 12 and over [ID6284]
In development Reference number: GID-TA11334 Expected publication date: TBC
in the diagnosis and assessment of babies showing non-IgE-mediated food allergy symptoms in primary care and community settings? Any...